title: Crimean-Congo hemorrhagic fever: an overview.
abstract: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that is a serious threat to humans. The disease is widely distributed in Africa, Asia, and Europe and has developed into a serious public health concern. Humans become infected through the bites of ticks, by contact with a patient with CCHF, or by contact with blood or tissues from viremic livestock. Microvascular instability and impaired hemostasis are the hallmarks of the infection. Infection in human begins with nonspecific febrile symptoms, but may progress to a serious hemorrhagic syndrome with high mortality rates. Enzyme-linked immunoassay (ELISA) and polymerase chain reaction (PCR) are the most used and specific tests for the diagnosis. The mainstay of treatment is supportive. Although definitive studies are not available, ribavirin is suggested to be effective especially at the earlier phase of the infection. Uses of universal protective measures are the best way to avoid the infection. In this review, all aspects of CCHF are overviewed in light of the current literature.
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Adnan Menderes University Medical Faculty, Aydin 09100, Turkey. soncu@dr.com
authors.forename: Serkan
authors.initials: S
authors.lastname: Oncü
mesh_terms: D000349:Africa / Q000453:epidemiology; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D001208:Asia / Q000453:epidemiology; D003140:Communicable Disease Control / Q000379:methods; D005060:Europe / Q000453:epidemiology; D006479:Hemorrhagic Fever, Crimean / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology* / Q000628:therapy; D006801:Humans; D012254:Ribavirin / Q000627:therapeutic use; D013987:Ticks / Q000821:virology*; D015047:Zoonoses / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology* / Q000628:therapy
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin
references.citation: Clin Infect Dis. 2007 Oct 1;45(7):e96-100
references.pmid: 17806044
references.citation: Int J Infect Dis. 2011 Jul;15(7):e459-63
references.pmid: 21546303
references.citation: J Infect. 2009 Mar;58(3):238-44
references.pmid: 19246100
references.citation: Int J Infect Dis. 2010 Aug;14(8):e704-7
references.pmid: 20627646
references.citation: Arch Iran Med. 2009 Mar;12(2):151-3
references.pmid: 19249885
references.citation: Int J Infect Dis. 2011 Jan;15(1):e44-7
references.pmid: 21106428
references.citation: Virol J. 2008 Jan 15;5:7
references.pmid: 18197964
references.citation: Jpn J Infect Dis. 2009 Jan;62(1):11-5
references.pmid: 19168952
references.citation: Antiviral Res. 2004 Dec;64(3):145-60
references.pmid: 15550268
references.citation: J Antimicrob Chemother. 2011 Jun;66(6):1215-22
references.pmid: 21482564
references.citation: J Clin Virol. 2010 Feb;47(2):110-4
references.pmid: 20006541
references.citation: Lancet Infect Dis. 2006 Apr;6(4):203-14
references.pmid: 16554245
references.citation: Int J Infect Dis. 2009 Nov;13(6):e431-6
references.pmid: 19409826
references.citation: East Mediterr Health J. 2012 May;18(5):522-6
references.pmid: 22764441
references.citation: East Afr J Public Health. 2010 Mar;7(1):20-9
references.pmid: 21413568
references.citation: Med Hypotheses. 2007;68(4):924-5
references.pmid: 17056187
references.citation: Lancet. 1995 Aug 19;346(8973):472-5
references.pmid: 7637481
references.citation: J Glob Infect Dis. 2011 Jul;3(3):285-92
references.pmid: 21887063
references.citation: Scand J Infect Dis. 2011 Mar;43(3):225-9
references.pmid: 21142621
references.citation: Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S43-6
references.pmid: 20810253
references.citation: J Vector Borne Dis. 2012 Jun;49(2):105-10
references.pmid: 22898483
references.citation: Jpn J Infect Dis. 2011;64(5):439-43
references.pmid: 21937830
references.citation: Int J Infect Dis. 2012 Aug;16(8):e616-20
references.pmid: 22695238
references.citation: Am J Trop Med Hyg. 1985 Nov;34(6):1179-82
references.pmid: 2422968
references.citation: J Med Virol. 2005 Sep;77(1):83-8
references.pmid: 16032715
references.citation: Epidemiol Infect. 1994 Dec;113(3):551-62
references.pmid: 7995364
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):929-33
references.pmid: 19301047
references.citation: Nat Med. 2004 Dec;10(12 Suppl):S110-21
references.pmid: 15577929
references.citation: Curr Opin Virol. 2012 Apr;2(2):215-20
references.pmid: 22482717
references.citation: J Virol. 2006 Sep;80(17):8834-42
references.pmid: 16912331
references.citation: Antiviral Res. 1993 Dec;22(4):309-25
references.pmid: 8279818
references.citation: Vector Borne Zoonotic Dis. 2012 Sep;12(9):805-11
references.pmid: 22607078
references.citation: Methods Mol Biol. 2011;665:357-68
references.pmid: 21116810
references.citation: J Med Microbiol. 2005 Apr;54(Pt 4):385-389
references.pmid: 15770025
references.citation: Jpn J Infect Dis. 2004 Apr;57(2):55-7
references.pmid: 15118210
references.citation: Emerg Infect Dis. 2012 Dec;18(12):1958-65
references.pmid: 23171700
references.citation: PLoS Negl Trop Dis. 2012;6(5):e1653
references.pmid: 22616022
references.citation: J Assoc Physicians India. 2011 Mar;59:164-7
references.pmid: 21751625
references.citation: Clin Infect Dis. 2004 Jul 15;39(2):284-7
references.pmid: 15307042
references.citation: Vet Parasitol. 2012 May 25;186(3-4):546-52
references.pmid: 22119389
references.citation: J Clin Virol. 2006 Aug;36(4):272-6
references.pmid: 16765637
references.citation: Ticks Tick Borne Dis. 2012 Apr;3(2):95-9
references.pmid: 22300969
references.citation: Expert Rev Anti Infect Ther. 2010 Jan;8(1):33-50
references.pmid: 20014900
references.citation: J Infect Dis. 2006 Apr 1;193(7):941-4
references.pmid: 16518755
references.citation: Med Arh. 2010;64(2):91-3
references.pmid: 20514773
references.citation: Vector Borne Zoonotic Dis. 2012 Sep;12(9):812-6
references.pmid: 22007611
references.citation: Vector Borne Zoonotic Dis. 2012 Sep;12(9):786-93
references.pmid: 22217175
references.citation: Scand J Infect Dis. 2012 Apr;44(4):276-81
references.pmid: 22017179
references.citation: Virus Res. 2004 Jun 15;102(2):185-9
references.pmid: 15084400
references.citation: Klin Med (Mosk). 2012;90(4):59-62
references.pmid: 22896984
references.citation: Antiviral Res. 2008 Apr;78(1):125-31
references.pmid: 18096251
references.citation: Infect Genet Evol. 2009 Sep;9(5):948-54
references.pmid: 19560561
references.citation: Enferm Infecc Microbiol Clin. 2005 Nov;23(9):560-8
references.pmid: 16324569
references.citation: J Clin Microbiol. 1986 Oct;24(4):654-6
references.pmid: 3095367
references.citation: Clin Lab Med. 2006 Jun;26(2):345-86, viii
references.pmid: 16815457
references.citation: Am J Trop Med Hyg. 2007 Mar;76(3):443-5
references.pmid: 17360865
references.citation: BMC Infect Dis. 2010 Jul 13;10:207
references.pmid: 20626907
references.citation: Int J Infect Dis. 2012 Feb;16(2):e89-93
references.pmid: 22154082
references.citation: J Clin Virol. 2010 Jul;48(3):184-6
references.pmid: 20444644
references.citation: J Clin Microbiol. 2002 Jul;40(7):2323-30
references.pmid: 12089242
references.citation: Emerg Infect Dis. 2012 Apr;18(4):640-2
references.pmid: 22469474
references.citation: Vopr Virusol. 2011 Jul-Aug;56(4):34-8
references.pmid: 21899068
references.citation: J Infect. 2006 Mar;52(3):207-15
references.pmid: 15953646
references.citation: Antiviral Res. 2011 May;90(2):85-92
references.pmid: 21362441
references.citation: J Virol. 2010 Nov;84(21):11089-100
references.pmid: 20739514
references.citation: Int J Infect Dis. 2010 Sep;14 Suppl 3:e349; author reply e350
references.pmid: 20034830
references.citation: Lancet. 1990 Mar 31;335(8692):791-2
references.pmid: 1969533
references.citation: J Pak Med Assoc. 2003 Jan;53(1):39-41
references.pmid: 12666854
references.citation: J Clin Virol. 2010 Jan;47(1):65-8
references.pmid: 19962342
references.citation: Arch Iran Med. 2007 Apr;10(2):204-14
references.pmid: 17367225
references.citation: Am J Trop Med Hyg. 1989 Nov;41(5):581-5
references.pmid: 2510529